ABT-301

· Anbogen Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-301, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC [Phase 1, Phase 2]

See pricing